Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
07/2003
07/23/2003EP1328273A2 Felodipine transdermal device and methods
07/23/2003EP1328265A2 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions
07/23/2003EP1328264A1 Use of estramustine phosphate in the treatment of bone metastasis
07/23/2003EP1328262A2 A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes
07/23/2003EP1328260A2 Methods and products related to pulmonary delivery of polysaccharides
07/23/2003EP1328259A2 Transdermal therapeutic systems comprising photosensitive active substances
07/23/2003EP1328258A1 A controlled-release, parenterally administrable microparticle preparation
07/23/2003EP1328257A2 Biodegradable bioadhesive controlled release system of nano-particles for oral care products
07/23/2003EP1328256A2 Valve for osmotic devices
07/23/2003EP1328255A1 Composition and method for stable injectable liquids
07/23/2003EP1328254A2 Lipid formulations for target delivery
07/23/2003EP1328253A2 Administration of a thiol-based chemoprotectant compound
07/23/2003EP1328252A2 Transdermal pharmaceutical delivery composition
07/23/2003EP1328251A2 Methylphenidate modified release formulations
07/23/2003EP1328250A2 Method for determining the release of a peptide from a sustained release polylactide formulation
07/23/2003EP1328236A2 Methods of decreasing or preventing pain using spicamycin derivatives
07/23/2003EP1328214A1 Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications
07/23/2003EP1328186A1 Methods for treating various eye disorders
07/23/2003EP1328184A2 Multicomponent biodegradable bioadhesive controlled release system for oral care products
07/23/2003EP1251826B1 Diclofenamide suspension gel
07/23/2003EP1223972B1 Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses
07/23/2003EP1189608B1 Levodopa/carbidopa/entacapone pharmaceutical preparation
07/23/2003EP1173154A4 Chewing gum with dental benefits including calcium in a food grade acid
07/23/2003EP1140199B1 Hyaluronate lyase used for promoting penetration in topical agents
07/23/2003EP1140006B1 Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis
07/23/2003EP1123106B1 Composition containing eugenol and polyphenols and use of such a composition for wound healing
07/23/2003EP1107741B1 Orally administered controlled drug delivery system providing temporal and spatial control
07/23/2003EP1077727B1 Adhesive microsphere drug delivery composition
07/23/2003EP1077717B1 Use of lipopeptides or lipoproteins for wound treatment
07/23/2003EP1073594B1 Metered dose valve for pharmaceutical aerosol
07/23/2003EP1069913B1 Gelling ophthalmic compositions containing xanthan gum
07/23/2003EP1035842A4 IMPROVED HMG CoA REDUCTASE INHIBITOR EXTENDED RELEASE FORMULATION
07/23/2003EP1019078B1 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis
07/23/2003EP1007024B1 Delayed-release dosage forms of sertraline
07/23/2003EP0957940B1 Pharmaceutical compositions containing gellants in the form of alkyl amides of di- and tri-carboxylic acids
07/23/2003EP0951294B1 Method of producing concentrated non-buffered solutions of fibronectin
07/23/2003EP0942724B1 Gel formulations for topical drug delivery
07/23/2003EP0874640B1 Cyclosporin formulation
07/23/2003EP0871476B1 Dried blood factor composition comprising trehalose
07/23/2003EP0855919B1 Induction of mucosal immune responses by vitamin d3 and antigen-encoding dna complexe to cationic lipid
07/23/2003EP0820290B1 Use of vitamin d 2 or vitamin d 4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
07/23/2003CN1432023A Reductive alkylation process on glycopeptides
07/23/2003CN1431971A Micropowdered barium sulfate
07/23/2003CN1431964A Methods of producing terminally sterilized topical patch preparation
07/23/2003CN1431919A Device and liquid formulations
07/23/2003CN1431916A Oral delivery method and compsn. for solid medications or dietary supplements
07/23/2003CN1431908A Kits and methods for optimizing efficacy of chondroprotective compsns.
07/23/2003CN1431906A Percutaneous absorption type steroid prepn. for external use
07/23/2003CN1431900A Methods and compsns. useful in enhancing oxygon delivery to cells
07/23/2003CN1431896A Oily compsns. contg. highly fat-soluble drugs
07/23/2003CN1431895A Compsns-and methods for trapping and inactivating pathogenic microbes and spermatozoa
07/23/2003CN1431041A Granular body contg. polydroxy alkoxide acid ester
07/23/2003CN1431017A Microcapsule meterial for durative releasing two factors for restraining new-born blood vessels and its preparing method
07/23/2003CN1431000A Adhibition ointment for relieving cough
07/23/2003CN1430998A Drip pills for curing aphtha and its preparing method
07/23/2003CN1430994A Chinese medical prepn. for preventing and curing cardiovascular, cerebrovascular diseases and its prodn. method
07/23/2003CN1430993A Spartina capsules for reducing blood fat and its prodn. technique
07/23/2003CN1430992A ÔÇÿXiangdanÔÇÖ drop liquid for treating angiocardiopathy
07/23/2003CN1430987A Chewing tablet of hydrochloric bastardtoad flax and creation technique
07/23/2003CN1430986A Compound zedoary oil ointment and its preparing method
07/23/2003CN1430984A Detoxification capsule and its prodn. methods
07/23/2003CN1430983A Liquid preparation of gingko leaves and its preparing method
07/23/2003CN1430982A Capsule of astragalus and honey as well as its preparing technique
07/23/2003CN1430978A Astragalus cream of female use and its preparing method
07/23/2003CN1430974A Musk capsule for anti-thrombus
07/23/2003CN1430970A Application of Nano copper powder for preparing medicine for prophylaxis of osteoporosis and bone fracture
07/23/2003CN1430965A Soft capsule of puerarin and preparing method thereof
07/23/2003CN1430963A Slowly releasing tablet of ligustrazine of phosphoric acid and its preparing method
07/23/2003CN1430955A Paste for curing premature ejaculation
07/23/2003CN1430954A Soft capsule in total flavone of hawthorn leaves and its preparing method
07/23/2003CN1430953A Tablet disintegzated in mouth rapidly for preventing and curing vomit and preparing method
07/23/2003CN1430952A Asiaticoside liposome and its use
07/23/2003CN1430918A Method for producing capsules of black tree mushroom
07/23/2003CN1115161C Aitonging plaster for treating cancer and its prepn. method
07/23/2003CN1115159C Red sage contg. medicine compsn. and its prepn. process and application
07/23/2003CN1115152C Method for treating bronchitis with uridine triphosphates and related compounds
07/23/2003CN1115149C Aqueous process for mfg. paroxetine solid dispersions
07/23/2003CN1115148C Skin penetration enhancing components
07/22/2003US6597947 Iontophoresis device
07/22/2003US6597004 Powdered far-infrared radiator and method of making the same
07/22/2003US6596874 Salt formation by reaction using benzenesulfonic acid
07/22/2003US6596844 Flowable, have an increased bulk density, and a low amount of dust
07/22/2003US6596791 Polymer complexes of glucuronoglucanes
07/22/2003US6596779 Stable emulsion, process for the preparation thereof and agent for this purpose
07/22/2003US6596777 Moisture containing compositions that are spreadable onto and adherable to biomembranes
07/22/2003US6596763 Method for counteracting infections caused by bacteria, fungi or virus such as Herpes Simplex Virus in skin or mucosal membranes, in particular genital membranes, of a mammal. The method comprises topically administering to skin or mucous
07/22/2003US6596755 An oral formulation comprising an imino acid conjugate of methylglyoxal of Structure (I) treating cancer of the lung, colon, pancreas, oral, prostate, glioblastoma or lukemia comprising administering a formulation of an imino acid
07/22/2003US6596740 Nicotine mucosal spray
07/22/2003US6596714 parasiticidal formulation for oral administration, comprising the mixture of: edible, non-aqueous liquid; thickening agent; agent effective against nematodes and obligate parasitic flies; and cestocidal agent, wherein said cestocidal agent is
07/22/2003US6596711 GABA B receptor agonists for use in the treatment of CNS disorders, such as muscle relaxation in spinal spasticity, cardiovascular disorders, asthma, gut motility disorders such as irritable bowel syndrome and gastroesophogeal reflux
07/22/2003US6596710 Dosage forms of risedronate
07/22/2003US6596704 Spraying, painting or squirting gellan gum composition on the wound or skin injury to form an immobile gel
07/22/2003US6596697 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
07/22/2003US6596543 Use of liposomes of defined composition and size for the preparation of prothrombin time reagents
07/22/2003US6596317 Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it
07/22/2003US6596316 Adjusting the degree of drying creates intial burst then linear release; drug delivery; may comprise risperidone within ethyl acetate/benzyl alcohol solvent blend
07/22/2003US6596315 Minimizing degradation; dissolveing acid labile substance in hydrate form and applying a fluid gas
07/22/2003US6596314 Controlled release liquid active agent formulation dosage forms
07/22/2003US6596313 Nutritional supplement and methods of using it
07/22/2003US6596312 Hydrolyzed cellulose granulations of salts of drugs